ASX - By Stock
|
SPL |
Re:
Publication we have all been waiting on
|
|
peony-rose
|
19 |
5.2K |
0 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
19
|
5.2K
|
0
|
|
ASX - By Stock
|
Medicine |
Re:
Amyloidosis
|
|
peony-rose
|
7 |
1.7K |
0 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
7
|
1.7K
|
0
|
|
ASX - By Stock
|
CBA |
Re:
CBA TA update
|
|
peony-rose
|
1.5K |
542K |
2 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
1.5K
|
542K
|
2
|
|
ASX - By Stock
|
CBA |
Re:
CBA TA update
|
|
peony-rose
|
1.5K |
542K |
4 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
1.5K
|
542K
|
4
|
|
ASX - By Stock
|
CBA |
Re:
CBA TA update
|
|
peony-rose
|
1.5K |
542K |
7 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
1.5K
|
542K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Dep Cabazitaxel effective against stage III cholangiocarcinoma
|
|
peony-rose
|
7 |
3.2K |
3 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
7
|
3.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Dep Cabazitaxel effective against stage III cholangiocarcinoma
|
|
peony-rose
|
7 |
3.2K |
1 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
7
|
3.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Dep Cabazitaxel effective against stage III cholangiocarcinoma
|
|
peony-rose
|
7 |
3.2K |
3 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
7
|
3.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in substantial holding
|
|
peony-rose
|
17 |
4.1K |
4 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
17
|
4.1K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
SPL shares today but one buyer is OTT cheap
|
|
peony-rose
|
7 |
1.7K |
1 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
7
|
1.7K
|
1
|
|
ASX - By Stock
|
CBA |
Re:
As if CBA has no bad debts
|
|
peony-rose
|
7 |
1.6K |
2 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
7
|
1.6K
|
2
|
|
ASX - By Stock
|
CBA |
Re:
CBA TA update
|
|
peony-rose
|
1.5K |
542K |
5 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
1.5K
|
542K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma to collaborate with UTS and CSIRO for mRNA vaccine for Urinary Tract Infections
|
|
peony-rose
|
5 |
1.4K |
0 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
5
|
1.4K
|
0
|
|
ASX - By Stock
|
CBA |
Re:
CBA TA update
|
|
peony-rose
|
1.5K |
542K |
1 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
1.5K
|
542K
|
1
|
|
ASX - By Stock
|
CBA |
Re:
CBA TA update
|
|
peony-rose
|
1.5K |
542K |
2 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
1.5K
|
542K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Biden gets covid-19
|
|
peony-rose
|
33 |
6.0K |
2 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
33
|
6.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
manipulation at its best
|
|
peony-rose
|
66 |
17K |
4 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
66
|
17K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
New COMPETITION for antiviral nasal sprays
|
|
peony-rose
|
32 |
9.0K |
0 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
32
|
9.0K
|
0
|
|
ASX - By Stock
|
Medicine |
Re:
Amyloidosis
|
|
peony-rose
|
7 |
1.7K |
1 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
7
|
1.7K
|
1
|
|
ASX - By Stock
|
Medicine |
Re:
Amyloidosis
|
|
peony-rose
|
7 |
1.7K |
0 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
7
|
1.7K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma Delegation @ ASCO 2024
|
|
peony-rose
|
22 |
6.6K |
1 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
22
|
6.6K
|
1
|
|
ASX - By Stock
|
HDN |
Re:
News: HDN Homeco Daily Needs REIT Says FY24 DPU Guidance Of 8.3 AU Cents Reaffirmed
|
|
peony-rose
|
23 |
6.7K |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
23
|
6.7K
|
0
|
|
ASX - By Stock
|
HDN |
Re:
News: HDN Homeco Daily Needs REIT Says FY24 DPU Guidance Of 8.3 AU Cents Reaffirmed
|
|
peony-rose
|
23 |
6.7K |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
23
|
6.7K
|
0
|
|
ASX - By Stock
|
CBA |
Re:
CBA TA update
|
|
peony-rose
|
1.5K |
542K |
14 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.5K
|
542K
|
14
|
|
ASX - By Stock
|
SPL |
Re:
Dep Irinotecan slide deck
|
|
peony-rose
|
9 |
2.3K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
9
|
2.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Dep Irinotecan slide deck
|
|
peony-rose
|
9 |
2.3K |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
9
|
2.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Tax loss selling season is officially here
|
|
peony-rose
|
13 |
2.5K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
13
|
2.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Tax loss selling season is officially here
|
|
peony-rose
|
13 |
2.5K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
13
|
2.5K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
peony-rose
|
15 |
3.7K |
6 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
15
|
3.7K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
peony-rose
|
42 |
12K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
42
|
12K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
peony-rose
|
42 |
12K |
6 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
42
|
12K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
C'mon Friday 24th May
|
|
peony-rose
|
12 |
3.3K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
12
|
3.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification - SPL Business Update
|
|
peony-rose
|
44 |
11K |
3 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
44
|
11K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification - SPL Business Update
|
|
peony-rose
|
44 |
11K |
5 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
44
|
11K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification - SPL Business Update
|
|
peony-rose
|
44 |
11K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
44
|
11K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
peony-rose
|
53 |
12K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
53
|
12K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
peony-rose
|
29 |
7.0K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
7.0K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
peony-rose
|
29 |
7.0K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
7.0K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
ASCO Presentations 2024
|
|
peony-rose
|
29 |
7.0K |
3 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
29
|
7.0K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Why no SPL announcement on TGA decison
|
|
peony-rose
|
13 |
2.8K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
2.8K
|
2
|
|
ASX - By Stock
|
HCW |
Re:
Ann: Trading Update
|
|
peony-rose
|
4 |
2.5K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
4
|
2.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
161 |
37K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
161
|
37K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification SPL Medicxi Partnership
|
|
peony-rose
|
32 |
7.5K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
32
|
7.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
161 |
37K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
161
|
37K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
161 |
37K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
161
|
37K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
161 |
37K |
9 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
161
|
37K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
161 |
37K |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
161
|
37K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
peony-rose
|
161 |
37K |
8 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
161
|
37K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Interim decision to amend the Poison Standard for astodrimer sodium
|
|
peony-rose
|
32 |
8.5K |
7 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
32
|
8.5K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's new website
|
|
peony-rose
|
5 |
1.4K |
0 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
5
|
1.4K
|
0
|
|